Transcatheter Aortic Valve Replacement for Severe Native Aortic Valve Regurgitation: A Multicenter and International Registry.

Authors

• Sant Kumar
• Ashish Pershad
• David Elison
• EiEi Thwe
• Jacopo Farina
• Ahmad Jabri
• Ivan Hanson, Corewell Health East
• Amr Abbas, Corewell Health East
• Pedro A Villablanca
• Nezar Falluji

Document Type

Article

Publication Date

3-1-2026

Publication Title

Structural heart : the journal of the Heart Team

Abstract

Transcatheter aortic valve replacement for native aortic valve regurgitation is feasible but with modest technical success (79.8%).•Balloon-expandable valve use is linked to lower 30-day major adverse cardiac events versus self-expanding valve in high-risk patients.•Long-term outcomes driven by patient risk, not valve type.•Dedicated native aortic regurgitation systems still needed to improve procedural safety.

Volume

10

Issue

3

First Page

100762

Recommended Citation

Kumar S, Pershad A, Elison D, Thwe E, Farina J, Jabri A et al [Hanson I, Abbas A] Transcatheter aortic valve replacement for severe native aortic valve regurgitation: a multicenter and international registry. Struct Heart. 2025 Nov 15;10(3):100762. doi: 10.1016/j.shj.2025.100762. PMID: 41766953

DOI

10.1016/j.shj.2025.100762

ISSN

2474-8714

PubMed ID

41766953